<VariationArchive VariationID="976443" VariationName="NM_015100.4(POGZ):c.3360dup (p.Met1121fs)" VariationType="Duplication" Accession="VCV000976443" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2020-08-17" MostRecentSubmission="2020-08-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="964710" VariationID="976443">
      <GeneList>
        <Gene Symbol="POGZ" FullName="pogo transposable element derived with ZNF domain" GeneID="23126" HGNC_ID="HGNC:18801" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="151402724" stop="151459494" display_start="151402724" display_stop="151459494" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="151375199" stop="151431940" display_start="151375199" display_stop="151431940" Strand="-" />
          </Location>
          <OMIM>614787</OMIM>
          <Haploinsufficiency last_evaluated="2017-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POGZ">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POGZ">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015100.4(POGZ):c.3360dup (p.Met1121fs)</Name>
      <CanonicalSPDI>NC_000001.11:151405674:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="151405674" stop="151405675" display_start="151405674" display_stop="151405675" variantLength="1" positionVCF="151405674" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="151378150" stop="151378151" display_start="151378150" display_stop="151378151" variantLength="1" positionVCF="151378150" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>M1026fs</ProteinChange>
      <ProteinChange>M1059fs</ProteinChange>
      <ProteinChange>M1068fs</ProteinChange>
      <ProteinChange>M1112fs</ProteinChange>
      <ProteinChange>M1121fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.151378151dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.151378151dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.151405675dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.151405675dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046601.1" sequenceAccession="NG_046601" sequenceVersion="1" change="g.58791dup">
            <Expression>NG_046601.1:g.58791dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001194937.2" sequenceAccession="NM_001194937" sequenceVersion="2" change="c.3333dup">
            <Expression>NM_001194937.2:c.3333dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001181866.1" sequenceAccession="NP_001181866" sequenceVersion="1" change="p.Met1112fs">
            <Expression>NP_001181866.1:p.Met1112fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001194938.2" sequenceAccession="NM_001194938" sequenceVersion="2" change="c.3174dup">
            <Expression>NM_001194938.2:c.3174dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001181867.1" sequenceAccession="NP_001181867" sequenceVersion="1" change="p.Met1059fs">
            <Expression>NP_001181867.1:p.Met1059fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015100.4" sequenceAccession="NM_015100" sequenceVersion="4" change="c.3360dup" MANESelect="true">
            <Expression>NM_015100.4:c.3360dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055915.2" sequenceAccession="NP_055915" sequenceVersion="2" change="p.Met1121fs">
            <Expression>NP_055915.2:p.Met1121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145796.4" sequenceAccession="NM_145796" sequenceVersion="4" change="c.3075dup">
            <Expression>NM_145796.4:c.3075dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_665739.3" sequenceAccession="NP_665739" sequenceVersion="3" change="p.Met1026fs">
            <Expression>NP_665739.3:p.Met1026fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207171.2" sequenceAccession="NM_207171" sequenceVersion="2" change="c.3201dup">
            <Expression>NM_207171.2:c.3201dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997054.1" sequenceAccession="NP_997054" sequenceVersion="1" change="p.Met1068fs">
            <Expression>NP_997054.1:p.Met1068fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1653455584" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015100.4(POGZ):c.3360dup (p.Met1121fs) AND Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" Accession="RCV001253757" Version="2">
        <ClassifiedConditionList TraitSetID="21504">
          <ClassifiedCondition DB="MedGen" ID="C4225351">Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-03-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-03-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-08-17" MostRecentSubmission="2020-08-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="21504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33338" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome</ElementValue>
                <XRef ID="MONDO:0014606" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRD37</ElementValue>
                <XRef Type="MIM" ID="616364" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WHSUS</ElementValue>
                <XRef Type="MIM" ID="616364" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems. Additional features commonly reported include seizures, refractive errors and strabismus, hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females.</Attribute>
                <XRef ID="NBK573972" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13774" />
                <XRef ID="13774" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34529370</ID>
                <ID Source="BookShelf">NBK573972</ID>
              </Citation>
              <XRef ID="468678" DB="Orphanet" />
              <XRef ID="C4225351" DB="MedGen" />
              <XRef ID="MONDO:0014606" DB="MONDO" />
              <XRef Type="MIM" ID="616364" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2820786" SubmissionDate="2020-08-07" DateLastUpdated="2020-08-17" DateCreated="2020-08-17">
        <ClinVarSubmissionID localKey="SUB7897837" submittedAssembly="GRCh37" title="SUB7897837" />
        <ClinVarAccession Accession="SCV001427031" DateUpdated="2020-08-17" DateCreated="2020-08-17" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Stanford Medicine" OrgID="507411" OrganizationCategory="laboratory" OrgAbbreviation="CGP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Met1121Tyrfs*6 variant in the POGZ gene was identified de novo in this individual, but has not been previously reported in association with disease. This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). The p.Met1121Tyrfs*6 variant results in a one base pair duplication, which causes a shift in the protein reading frame, leading to a premature termination codon 6 amino acids downstream. Premature termination at this location is not predicted to lead to nonsense-mediated decay. Other de novo truncating variants have been reported in association with disease in the literature, including several that are downstream of this p.Met1121Tyrfs*6 variant (Stessman et al., 2016). These data were assessed using the ACMG/AMP variant interpretation guidelines (Richards et al., 2015). In summary, the p.Met1121Tyrfs*6 is considered pathogenic. [ACMG evidence codes used: PVS1_Strong, PS2, PM2]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POGZ">
              <Name>pogo transposable element derived with ZNF domain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Met1121Tyrfs*6</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015100.3:c.3360dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616364" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7897837</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2820786" TraitType="Disease" MappingType="XRef" MappingValue="616364" MappingRef="OMIM">
        <MedGen CUI="C4225351" Name="Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

